EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of High‐Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins During Reverse Remnant‐Cholesterol Transport in Familial Hypercholesterolemia

Shiva Ganjali, Judy B de Haan, Wilfried Le Goff, Anatol Kontush, Amirhossein Sahebkar

Endocrinology, Diabetes & Metabolism · 2026-07 · 9 (4)

DOI: 10.1002/edm2.70269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 02.07.2026. Verfasst von Shiva Ganjali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Triglycerides, Cholesterol, Lipoproteins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

High‐density lipoprotein (HDL) serves as a key protective factor against elevated low‐density lipoprotein cholesterol (LDL‐C) levels in patients with familial hypercholesterolemia (FH). This study aimed to assess whether HDL's ability to acquire free cholesterol (FC) from triglyceride‐rich lipoproteins (TGRLs) during lipolysis, as a part of reverse remnant‐cholesterol transport (RRT) pathway, is impaired in FH patients.

Methods

This case–control study included 16 homozygous (HOFH) and 18 heterozygous (HEFH) patients with FH, along with 20 healthy controls. The free cholesterol transfer assay measured the ability of HDL (as apoB‐depleted serum) to uptake fluorescently labelled free cholesterol (TopF) from TGRLs during lipoprotein lipase (LPL)‐mediated lipolysis.

Results

No significant difference was observed among the groups in the overall capacity of HDL to acquire FC from TGRLs during LPL‐mediated lipolysis. When normalizing for LDL‐C and non‐HDL‐C levels, significantly lower TopF transfer/LDL‐C and TopF transfer/non‐HDL‐C ratios were observed in HOFH patients in comparison with HEFH and healthy subjects. Lower TopF transfer/LDL‐C (OR: 0.605, 95% CI: 0.428–0.857; p < 0.01) and TopF transfer/non‐HDL‐C (OR: 0.539, 95% CI: 0.339–0.859; p < 0.01) ratios were independently associated with HOFH, while, after adjusting for age only the former association remained significant (OR: 0.646, 95% CI: 0.430–0.971).

Conclusion

Although HDL's direct capacity to acquire free cholesterol from TGRLs did not differ significantly between the groups, the reduced TopF transfer/LDL‐C and TopF transfer non‐HDL‐C ratios in FH patients is consistent with impaired HDL function. These ratios may serve as a potential biomarker for identifying high‐risk FH phenotypes, warranting validation in larger, prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IITriglyceridesCholesterolLipoproteinsLipoproteins, HDLHumansFemaleMaleCase-Control StudiesAdultMiddle AgedBiological TransportLipolysisLipoprotein Lipase

Stichwörter der Autor:innen

HDLfamilial hypercholesterolemiareverse remnant‐cholesterol transport

Substanzen

TriglyceridesCholesterolLipoproteinsLipoproteins, HDLLipoprotein Lipaseremnant-like particle cholesterol

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Cardiovascular Inflammation and Redox Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Sorbonne Université, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, Paris, France.
  • Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
  • Applied Biomedical Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Ganjali, S., de Haan, J. B., Le Goff, W., Kontush, A., & Sahebkar, A. (2026). Evaluation of High‐Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins During Reverse Remnant‐Cholesterol Transport in Familial Hypercholesterolemia. Endocrinology, Diabetes & Metabolism, 9(4). https://doi.org/10.1002/edm2.70269

Vancouver

Ganjali S, de Haan JB, Le Goff W, Kontush A, Sahebkar A. Evaluation of High‐Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins During Reverse Remnant‐Cholesterol Transport in Familial Hypercholesterolemia. Endocrinology, Diabetes & Metabolism. 2026;9(4). doi:10.1002/edm2.70269

BibTeX
@article{Ganjali2026,
  author = {Ganjali, Shiva and de Haan, Judy B and Le Goff, Wilfried and Kontush, Anatol and Sahebkar, Amirhossein},
  title = {Evaluation of High‐Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins During Reverse Remnant‐Cholesterol Transport in Familial Hypercholesterolemia},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {4},
  doi = {10.1002/edm2.70269}
}
Kostenlos starten →